Skip to main content

Structure Activity Relationships for Adenosine Agonists

  • Conference paper
Purines in Cellular Signaling

Abstract

Adenosine elicits a wide variety of physiological responses (Williams, 1987) via interactions with two major subtypes of extracellular adenosine receptors, designated as A1 and A2. These two receptor subtypes can be distinguished on the basis of structure-activity relationships (Hamprecht et al., 1985) and have opposite effects on adenylate cyclase (Londos et al., 1980). With the advent of an A2 binding assay (Bruns et al., 1986, Yeung et al., 1984), it has become possible to quantitatively evaluate the subtype selectivity of adenosine agonists. Recently, considerable effort has been devoted to the search for adenosine agonists with high selectivity for either A1 or A2 receptors. Our interest in adenosine receptors began with earlier disclosures that adenosine agonists such as R-PIA (Snyder et al., 1981), NECA (Prasad et al., 1980) or CV-1808 (Kawazoe et al., 1980) had potential utility as therapeutic agents (Figure 1). Thus, we set, out to develop structure-activity relationships (SAR) for both A1 and A2 receptors and especially to identify receptor selective agonists.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bridges, A.J., 1989, Nucleosides and Nucleotides 8(3):357.

    Article  CAS  Google Scholar 

  • Bridges, A.J., Moos, W.H., Szotek, D.L., Trivedi, B.K., Bristol, J.A., Heffner, T.G., Bruns, R.F., Downs, D.A., 1987, J. Med. Chem. 30:1709.

    Article  PubMed  CAS  Google Scholar 

  • Bridges, A. J., Bruns, R. F., Ortwine, D. F., Priebe, S. R., Szotek, D. L., Trivedi, B. K., 1988, J. Med. Chem. 31:1282.

    Article  PubMed  CAS  Google Scholar 

  • Bruns, R. F., Lu, G. H., Pugsley, T. A., 1986, Mol. Pharmacol. 29:331.

    PubMed  CAS  Google Scholar 

  • Daly, J. W., Padgett, W., Thompson, R. D., Kusachi, S., Bugni, W. J., Olsson, R. A., 1986, Biochem. Pharmacol. 35:2467.

    Article  PubMed  CAS  Google Scholar 

  • Hamprecht, B., van Calker, D., 1985, Trends Pharmacol. Sci. 6:153.

    Article  CAS  Google Scholar 

  • Kawazoe, K., Matsumoto, N., Tanabe, N., Fujiwara, S., Yanajimoto, M., Hirata, M., Kikuchi, K., 1980, Arzneim.-Forsch. 30:1083.

    CAS  Google Scholar 

  • Londos, C., Cooper, D. M. F., Wolff, J., 1980, Proc. Natl. Acad. Sci. U.S.A. 77:2551.

    Article  PubMed  CAS  Google Scholar 

  • Marumoto, R., Yoshikoto, Y., Miyashita, O., Shima, S., Imai, K., Kawazoe, K., Honjo, M., 1975, Chem. Pharm. Bull. 23:759.

    PubMed  CAS  Google Scholar 

  • Marumoto, R., Omura, K., Furukawa, Y., 1981, Chem. Pharm. Bull. 29:1870.

    Google Scholar 

  • Moos, W. H., Szotek, D. L., Bruns, R. F., 1985, J. Med. Chem. 28:1383.

    Article  PubMed  CAS  Google Scholar 

  • Ortwine, D. F., Bridges, A. J., Humblet, C., Trivedi, B. K., 1990, see chapter in this book.

    Google Scholar 

  • Prasad, R. N., Bariana, D. S., Fung, A., Savic, M., Tietje, K., Stein, H. H., Brondyk, H., Egan, R. S., 1980, J. Med. Chem. 23:313.

    Article  PubMed  CAS  Google Scholar 

  • Snyder, S. H., Katims, J. J., Annau, Z., Bruns, R. F., Daly, J. W., 1981, Proceedings of the National Academy of Sciences USA 78:3260.

    Article  CAS  Google Scholar 

  • Trivedi, B. K., Bristol, J. A., Bruns, R. F., Haleen, S. J., Steffen, R. P., 1988, J. Med. Chem. 31:271.

    Article  PubMed  CAS  Google Scholar 

  • Trivedi, B. K., 1988, Nucleosides and Nucleotides 7:393.

    Article  CAS  Google Scholar 

  • Trivedi, B. K., Bridges, A. J., Patt, W. C., Priebe, S. R., Bruns, R. F., 1989, J. Med. Chem. 32:8.

    Article  PubMed  CAS  Google Scholar 

  • Trivedi, B. K., Bruns, R. F., 1989, J. Med. Chem. 32:1667.

    Article  PubMed  CAS  Google Scholar 

  • Williams, M., 1987, Annu. Rev. Pharmacol. 27:315.

    Article  CAS  Google Scholar 

  • Yeung, S. M. H., Green, R. D., 1984, Naunyn-Schmiedeberg’s Arch. Pharmacol. 325:218.

    Article  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag New York Inc.

About this paper

Cite this paper

Trivedi, B.K. (1990). Structure Activity Relationships for Adenosine Agonists. In: Jacobson, K.A., Daly, J.W., Manganiello, V. (eds) Purines in Cellular Signaling. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3400-5_22

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-3400-5_22

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7996-9

  • Online ISBN: 978-1-4612-3400-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics